000272955 001__ 272955
000272955 005__ 20250715111246.0
000272955 0247_ $$2doi$$a10.5281/ZENODO.7904832
000272955 0247_ $$2doi$$a10.5281/zenodo.7904832
000272955 0247_ $$2doi$$a10.5281/zenodo.7904831
000272955 037__ $$aDZNE-2024-01334
000272955 1001_ $$0P:(DE-2719)9001970$$aLeonard, Hampton$$b0
000272955 245__ $$aDataset: Global Parkinson's Genetics Program Data Release 5, v1
000272955 260__ $$bZenodo$$c2023
000272955 3367_ $$2BibTeX$$aMISC
000272955 3367_ $$0PUB:(DE-HGF)32$$2PUB:(DE-HGF)$$aDataset$$bdataset$$mdataset$$s1732528429_17378
000272955 3367_ $$026$$2EndNote$$aChart or Table
000272955 3367_ $$2DataCite$$aDataset
000272955 3367_ $$2ORCID$$aDATA_SET
000272955 3367_ $$2DINI$$aResearchData
000272955 520__ $$aIn May 2023, GP2 announced the fifth data release on the Terra platform in collaboration with AMP® PD. This release includes 7,462 additional new complex disease participants and 487 new monogenic disease participants, adding to the previous releases from the Complex and Monogenic Networks. The complex disease data (genotypes) now consists of a total of 24,935 genotyped participants (12,728 PD cases, 10,533 Controls, and 1,674 ‘Other’ phenotypes). The monogenic disease data (whole genome sequences) now consists of a total of 722 sequenced participants. Please see the accompanying blog for further description of this release. To obtain data access, please see https://amp-pd.org/researchers/data-use-agreement . For any publications using data from this release, please reference the DOI number and the following statement: ' Data (DOI 10.5281/zenodo.7904832, release 5) used in the preparation of this article were obtained from the Global Parkinson’s Genetics Program (GP2).'
000272955 536__ $$0G:(DE-HGF)POF4-354$$a354 - Disease Prevention and Healthy Aging (POF4-354)$$cPOF4-354$$fPOF IV$$x0
000272955 588__ $$aDataset connected to DataCite
000272955 7001_ $$aNalls, Mike$$b1
000272955 7001_ $$aVitale, Dan$$b2
000272955 7001_ $$aKoretsky, Mathew$$b3
000272955 7001_ $$aLevine, Kristin$$b4
000272955 7001_ $$aMakarious, Mary$$b5
000272955 7001_ $$0P:(DE-2719)9001362$$aFang, Zih-Hua$$b6$$eLast author
000272955 773__ $$a10.5281/zenodo.7904832
000272955 7870_ $$0DZNE-2024-01333$$aBandres-Ciga, Sara et.al.$$dNew York, NY : Wiley, 2024$$iRelatedTo$$tNeuroBooster Array: A Genome-Wide Genotyping Platform to Study Neurological Disorders Across Diverse Populations.
000272955 909CO $$ooai:pub.dzne.de:272955$$pVDB
000272955 9141_ $$y2024
000272955 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001362$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000272955 9131_ $$0G:(DE-HGF)POF4-354$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Prevention and Healthy Aging$$x0
000272955 9201_ $$0I:(DE-2719)1210002$$kAG Heutink$$lGenome Biology of Neurodegenerative Diseases$$x0
000272955 980__ $$adataset
000272955 980__ $$aVDB
000272955 980__ $$aI:(DE-2719)1210002
000272955 980__ $$aUNRESTRICTED